OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out QIA/  DE000ME85F03  /

Stuttgart
07/11/2024  20:50:45 Chg.- Bid09:57:36 Ask09:57:36 Underlying Strike price Expiration date Option type
1.00EUR - 1.06
Bid Size: 40,000		 1.07
Ask Size: 40,000		 QIAGEN NV 30.6054 EUR 31/12/2078 Call
GlobeNewswire 28/08 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 26/08 Europe closes mixed amid Middle East crisis
GlobeNewswire 31/07 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 31/07 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 08/07 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 02/07 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 27/06 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 17/06 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 13/06 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 12/06 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 11/06 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 06/06 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 05/06 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 03/06 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 29/05 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 22/05 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 14/05 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 13/05 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 07/05 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 02/05 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 29/04 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance